JPRN-UMIN000022097已完成2 期
Feasibility Phase 2 study of Dose-dense AC or EC followed by PTX for operable breast cancer - Feasibility study of Dose-Dense therapy for early breast cancer
PO Setouchi Breast Project0 个研究点目标入组 50 人开始时间: 2016年4月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. distant metastasis 2. pregnancy or breast feeding 3. history of drug allergy 4. active infection 5. uncontrollable psychosis
研究者
相似试验
已完成
2 期
Phase 2 study of dose dense AC and dose dense PTX as perioperative chemotherapy for patients with HER2 negative breast cancer(WJOG9016B)HER2 negative breast cancerJPRN-UMIN000024992West Japan Oncology Group90
已完成
2 期
A study evaluating the safety of dose-dense EC with pegfilgrastim.breast cancerJPRN-UMIN000020834Fukuyama city hospital10
进行中（未招募）
不适用
A feasibility study of dose-dense FEC wiith G-CSF support followed by dose-dense Ixabepilone wiith G-CSF support as neoadjuvant chemotherapy in ER- negative breast cancer - GIM9 (NEO-ADIXERN)EUCTR2008-000486-29-ITCONSORZIO ONCOTECH
尚未招募
2 期
dose-dense AC or EC therapy followed by dose-dense Paclitaxel as neoadjuvant chemotherapy for triple negative operable breast cancerBreasr cancerJPRN-UMIN000040187Gifu University Graduate School of Medicine Department of Surgical Oncology35
已完成
2 期
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults with Systemic Lupus ErythematosusNL-OMON35833Astra Zeneca12